A push-button, automated solution for profiling cell health and death
Nanolive launches another ground-breaking tool in cell analysis: the LIVE Cell Death Assay, a push button, automated solution for profiling cell health, death, apoptosis and necrosis, label-free.
The LIVE Cell Death Assay (LCDA) provides first-in-class cytotoxicity analysis of dynamic label-free live cell data. Developed using state-of-the-art machine learning, the LCDA has been trained to discriminate not only living cells from dead cells, but also apoptosis from necrosis.
The LCDA has been created to be as user-friendly as possible: a single click of a button is required to launch the analysis. It delivers 13 viability and death-related metrics.
Watch the LIVE Cell Death Assay product video below!
Read our latest news
Next upcoming event
Next product launch - 26.06.2023
17 new scientific publications featuring Nanolive technology
Since the start of the year, 17 more papers have been published using Nanolive imaging, featuring an incredibly broad range of cell types; stem cells, adipocytes, neurons, osteoblasts, neutrophils, melanocytes, e. coli, primary synoviocytes, and several cancer cell...
Nanolive imaging confirms success of mesoestetic’s new treatment at the subcellular level
We are happy to see that Nanolive imaging has been used to confirm the success of another new therapy, this time treating melasma. In their latest paper “Depigmenting topical therapy based on a synergistic combination of compounds targeting the key pathways involved...
